TUMBARELLO, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 12.981
EU - Europa 5.463
AS - Asia 3.856
SA - Sud America 785
Continente sconosciuto - Info sul continente non disponibili 363
AF - Africa 233
OC - Oceania 11
Totale 23.692
Nazione #
US - Stati Uniti d'America 12.802
IT - Italia 2.175
RU - Federazione Russa 1.371
SG - Singapore 1.136
CN - Cina 926
BR - Brasile 645
VN - Vietnam 453
IE - Irlanda 440
HK - Hong Kong 388
KR - Corea 281
DE - Germania 238
FR - Francia 237
BD - Bangladesh 227
GB - Regno Unito 224
FI - Finlandia 169
SE - Svezia 167
ZA - Sudafrica 135
NL - Olanda 133
IN - India 132
CA - Canada 99
ES - Italia 50
PL - Polonia 45
MX - Messico 43
AT - Austria 40
IQ - Iraq 40
UA - Ucraina 38
AR - Argentina 37
JP - Giappone 30
TR - Turchia 29
CO - Colombia 27
EC - Ecuador 26
CZ - Repubblica Ceca 25
CI - Costa d'Avorio 24
ID - Indonesia 21
SA - Arabia Saudita 20
EG - Egitto 18
CH - Svizzera 17
UZ - Uzbekistan 17
AE - Emirati Arabi Uniti 16
KE - Kenya 16
LT - Lituania 15
BE - Belgio 14
MY - Malesia 14
PK - Pakistan 14
JO - Giordania 13
VE - Venezuela 13
PE - Perù 12
CL - Cile 11
IR - Iran 11
MA - Marocco 11
CR - Costa Rica 9
PY - Paraguay 9
AU - Australia 8
BG - Bulgaria 7
IL - Israele 7
NG - Nigeria 7
PH - Filippine 7
PT - Portogallo 7
BH - Bahrain 6
GE - Georgia 6
JM - Giamaica 6
PS - Palestinian Territory 6
AL - Albania 5
AZ - Azerbaigian 5
ET - Etiopia 5
HR - Croazia 5
KZ - Kazakistan 5
LK - Sri Lanka 5
LU - Lussemburgo 5
LV - Lettonia 5
TH - Thailandia 5
DK - Danimarca 4
GT - Guatemala 4
HU - Ungheria 4
KG - Kirghizistan 4
LB - Libano 4
SV - El Salvador 4
YE - Yemen 4
AM - Armenia 3
BY - Bielorussia 3
CY - Cipro 3
DZ - Algeria 3
GR - Grecia 3
NO - Norvegia 3
OM - Oman 3
RO - Romania 3
SC - Seychelles 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AO - Angola 2
BO - Bolivia 2
CG - Congo 2
DO - Repubblica Dominicana 2
FJ - Figi 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
PA - Panama 2
RS - Serbia 2
Totale 23.299
Città #
Dallas 9.455
Singapore 693
Milan 593
Moscow 453
San Jose 439
Dublin 423
Hefei 385
Hong Kong 357
Ashburn 346
Santa Clara 320
Seoul 280
Council Bluffs 233
Los Angeles 187
Ho Chi Minh City 174
Rome 169
Florence 164
Beijing 142
Siena 141
Chandler 116
Johannesburg 115
New York 111
Helsinki 102
The Dalles 96
Lauterbourg 94
Southend 87
Munich 86
Hanoi 83
Chicago 68
São Paulo 62
Bengaluru 56
Buffalo 55
Fairfield 54
Columbus 48
Nuremberg 46
Orem 45
Princeton 43
Figino 39
London 36
Brescia 35
Shanghai 35
Lappeenranta 34
Frankfurt am Main 31
Montreal 30
Naples 30
Turku 29
Bologna 28
Turin 26
Rio de Janeiro 25
Seattle 25
Tokyo 25
Toronto 25
Abidjan 24
Warsaw 24
Da Nang 22
Houston 22
Redondo Beach 22
Paris 20
Vienna 20
Denver 19
Brasília 18
Portsmouth 18
Stockholm 18
Washington 18
Woodbridge 18
Boardman 17
Boston 17
Gdynia 17
Chennai 16
Curitiba 16
Düsseldorf 16
Hải Dương 16
Jacksonville 16
Wilmington 16
Baghdad 15
Catania 15
Haiphong 15
Mexico City 15
Málaga 15
Palermo 15
Tashkent 15
Brooklyn 14
Atlanta 13
Brussels 13
Cape Town 13
Guangzhou 13
Mumbai 13
Newark 13
Zurich 13
Amman 12
Amsterdam 12
Belo Horizonte 12
Cairo 12
Miami 12
Phoenix 12
Poplar 12
San Diego 12
Bari 11
Brno 11
Figline Valdarno 11
Genoa 11
Totale 17.534
Nome #
(1,3)-β-d-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: A randomized trial 7.250
Compassionate use of meropenem/vaborbactam for infections caused by KPC-producing Klebsiella pneumoniae: a multicentre study 639
A first update on mapping the human genetic architecture of COVID-19 598
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 530
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 435
An explainable model of host genetic interactions linked to COVID-19 severity 382
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 381
Pathogen-sugar interactions revealed by universal saturation transfer analysis 370
Colonizzazione e trapianto di polmone: il possibile ruolo dei colonizzanti multiresistenti sugli eventi infettivi in uno studio pilota osservazionale-retrospettivo 326
null 320
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 311
Long Covid: analisi di casistica in follow-up a seguito di successive ondate epidemiche 310
Programma di vaccinazione antiMpox e screening infettivologico: opportunità di prevenzione in differenti categorie a rischio 309
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 301
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV 283
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 277
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes 257
Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants 248
Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder 225
Prevalence, Incidence and Predictors of Anal HPV Infection and HPV-Related Squamous Intraepithelial Lesions in a Cohort of People Living with HIV 223
B cell response six months after SARS-CoV-2 mRNA vaccination in people living with HIV under antiretroviral therapy 222
Whole-genome sequencing reveals host factors underlying critical COVID-19 209
Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responses 205
Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound? 199
Urinary tract infections caused by Gram-negative bacteria in elderly hospitalized patients: epidemiology, clinical features and outcomes in the era of antimicrobial resistance 195
Colonizzazione da batteri multiresistenti nel trapianto di polmone ed eventi infettivi: studio pilota osservazionale-retrospettivo 192
ACKNOWLEDGEMENT OF REVIEWERS 192
B cell analyses after SARS-CoV-2 mRNA third vaccination reveals a hybrid immunity like antibody response 190
Polypharmacy, anticholinergic burden and drug-drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registry 179
An Observational Study to Develop a Predictive Model for Bacterial Pneumonia Diagnosis in Severe COVID-19 Patients—C19-PNEUMOSCORE 177
Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis 174
Ceftazidime-avibactam use for klebsiella pneumoniae carbapenemase-producing k. pneumoniae infections: a retrospective observational multicenter study 168
Evolution of anal HPV infection and HPV-related squamous intraepithelial lesions in a cohort of PLWH: is there a benefit of HPV vaccination? 166
Patient profile characteristics when choosing different Dolutegravir-based dual therapies: impact on long term efficacy and durability 166
High prevalence of Hepatic Steatosis in a cohort of People Living With HIV: exploring the role of metabolic and HIV-related factors 161
Ceftolozane/tazobactam for treatment of severe ESBL-producing enterobacterales infections: A multicenter nationwide clinical experience (CEFTABUSE II Study) 161
Clinical impact of ceftazidime/avibactam on the treatment of suspected or proven infections in a large cohort of patients with haematological malignancies: a multicentre observational real-world study 160
Evaluation of the New NucliSENS EasyQ KPC Test for Rapid Detection of Klebsiella pneumoniae Carbapenemase Gene (blaKPC) 160
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine 159
Trattamento efficace di osteomielite sternale con raccolta purulenta da Klebsiella pneumoniae multiresistente in recente trapianto di polmone 158
Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey 154
Safety and Efficacy of Outpatient Treatments for COVID-19: Real-Life Data from a Regionwide Cohort of High-Risk Patients in Tuscany, Italy (the FEDERATE Cohort) 154
Vaccinazione anti SARSCov2 in una coorte di pazienti sottoposti a trapianto di cuore o di polmone: risposta umorale a dosi booster 152
Efficacy and Durability of Dolutegravir- or Darunavir-Based Regimens in ART-Naïve AIDS- or Late-Presenting HIV-Infected Patients. 152
PRESTIGIO RING “a 59-year-old man with multidrug resistant HIV-1 infection failing a regimen including dolutegravir, rilpivirine, atazanavir/cobicistat: successful treatment tailoring based on genotypic and phenotypic resistance tests” 151
Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants 151
Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant 150
Fatal inflammatory AIDS-associated PML with high CD4 counts on HAART: a new clinical entity? 146
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry 145
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine) 139
Outcomes and Predictors of Mortality in Patients With KPC-Kp Infections Treated With Meropenem Vaborbactam: An Observational Multicenter Study 138
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 137
Prevalence and correlates of Hepatic Steatosis and Metabolic-associated Fatty Liver Disease in a cohort of People Living With HIV 137
Successivi booster vaccinali contro SARS-CoV-2: risposta umorale in pazienti sottoposti a trapianto di cuore o di polmone 136
Liver fibrosis stage predicts early treatment outcomes with peginterferon plus ribavirin in HIV/hepatitis C virus co-infected patients 136
Rapid Decrease in Fluoroquinolones Consumption following Implementation of a Simple Antimicrobial Stewardship Bundled Intervention in a University Hospital during the COVID-19 Pandemic 133
Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey 126
Meropenem-vaborbactam as intrathecal-sparing therapy for the treatment of carbapenem-resistant K. pneumoniae shunt-related ventriculitis: two case reports and review of the literature 125
Diagnosis and management of infections caused by multidrug-resistant bacteria: guideline endorsed by the Italian Society of Infection and Tropical Diseases (SIMIT), the Italian Society of Anti-Infective Therapy (SITA), the Italian Group for Antimicrobial Stewardship (GISA), the Italian Association of Clinical Microbiologists (AMCLI) and the Italian Society of Microbiology (SIM) 120
Successful treatment of complicated infective endocarditis due to Enterococcus faecium in a patient with substance use disorder using oritavancin as sequential maintenance therapy 119
Characterisation and risk factor profiling of Pseudomonas aeruginosa urinary tract infections: pinpointing those likely to be caused by multidrug-resistant strains 119
A new call for influenza and pneumococcal vaccinations during COVID-19 pandemic in Italy: A SIP/IRS (Italian Respiratory Society) and SITA (Italian Society of Antiinfective therapy) statement 119
The Uprise of Human Leishmaniasis in Tuscany, Central Italy: Clinical and Epidemiological Data from a Multicenter Study 118
Third Sars-CoV-2 vaccine dose: B cell and antibody responses following heterologous and homologous vaccination strategies. 118
Persistence of spike-specific memory B cells and antibodies nine months after two doses of BNT162b2 mRNA vaccine. 114
Epidemiology, aetiology and treatment of skin and soft tissue infections: final report of a prospective multicentre national registry 111
Adjunctive immunotherapeutic agents in patients with sepsis and septic shock: a multidisciplinary consensus of 23 108
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 101
Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paper 99
Primary Cutaneous Cryptococcosis in an Immunocompetent Patient: Diagnostic Workflow and Choice of Treatment 98
Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use 97
New Drugs for the Treatment of Pseudomonas aeruginosa Infections with Limited Treatment Options: A Narrative Review 95
XDR-Pseudomonas aeruginosa Outside the ICU: Is There Still Place for Colistin? 94
Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study 93
Predictors of mortality in solid organ transplant recipients with bloodstream infections due to carbapenemase-producing Enterobacterales: The impact of cytomegalovirus disease and lymphopenia 92
Evaluating cefiderocol in the treatment of multidrug-resistant gram-negative bacilli: A review of the emerging data 89
Molecular mechanisms, epidemiology, and clinical importance of β-lactam resistance in enterobacteriaceae 88
Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae 85
Risk factors for candidemia after open heart surgery: Results from a multicenter case-control study 85
Clinical outcomes in elderly patients with infections caused by NDM-producing Klebsiella pneumoniae: results from a real-life retrospective single center study in an endemic area 82
Predictors for Prolonged Hospital Stay Solely to Complete Intravenous Antifungal Treatment in Patients with Candidemia: Results from the ECMM Candida III Multinational European Observational Cohort Study 82
Meropenem/vaborbactam: a next generation β-lactam β-lactamase inhibitor combination 82
Multicenter Observational Retrospective Study on Febrile Events in Patients with Acute Myeloid Leukemia Treated with Cpx-351 in "Real-Life": The SEIFEM Experience 81
Identification of two anti-Candida antibodies associated with the survival of patients with candidemia 81
Use of colistin in adult patients: A cross-sectional study 81
Posterior Reversible Encephalopathy Syndrome After Intramuscular Oxygen-Ozone Therapy 73
Factors associated with inadequate intravenous colistin dosages: Post hoc analysis of a multicenter, cross-sectional study 73
Invasive Respiratory Fungal Infections in COVID-19 Critically Ill Patients 72
How to tailor recommendations on the treatment of multi-drug resistant Gram-negative infections at country level integrating antibiotic stewardship principles within the GRADE-ADOLOPMENT framework 70
SARS CoV 2 infection in chronic myelogenous leukemia: Severe hematological presentation 70
Low rate of infectious mortality omitting fluoroquinolone prophylaxis in high-risk hematological patients, a single centre experience 68
SARS-CoV-2 infection in a highly experienced person living with HIV 66
Cefiderocol therapy among immunocompromised adult patients: a descriptive analysis from a prospective, multicentre cohort study 62
Can we lower the burden of antimicrobial resistance (AMR) in heavily immunocompromised patients? A narrative review and call to action 61
Treatment of post-lung transplantation pneumonia with cefiderocol: a case series and insights from the literature 43
The role of rapid and advanced microbiological methods in critical care: 2025 Emanuele Russo Delphi consensus 39
Diagnostic challenges in Flaviviridae infections: first human case of Usutu virus aseptic meningitis in an immunocompetent subject in Italy 33
Enterococcus faecium bacteraemia: a multicentre observational study focused on risk factors for clinical and microbiological outcomes 29
Machine learning approaches to dissect hybrid and vaccine-induced immunity 28
Mapping the human genetic architecture of COVID-19 19
Totale 23.587
Categoria #
all - tutte 60.126
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.126


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022295 0 9 2 8 4 3 31 57 13 26 53 89
2022/2023773 38 82 91 65 36 109 98 85 56 34 59 20
2023/20241.021 48 34 101 65 52 197 292 53 10 40 43 86
2024/20253.486 149 98 250 144 452 204 337 203 244 206 344 855
2025/202617.312 568 3.313 7.173 1.228 1.372 309 993 281 318 549 503 705
2026/2027615 576 39 0 0 0 0 0 0 0 0 0 0
Totale 23.692